Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 472421 - 472440 out of 476480 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01FX25) mosunetuzumab | LUNSUMIO 1MG/ML INJ,SOLN,1ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | GenentechUSA,Inc. |
| USA | (L01FX25) mosunetuzumab | LUNSUMIO 1MG/ML INJ,SOLN,1ML | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | GenentechUSA,Inc. |
| USA | (L01FX25) mosunetuzumab | LUNSUMIO 1MG/ML INJ,SOLN,30ML | 30ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | GenentechUSA,Inc. |
| USA | (L01FX25) mosunetuzumab | LUNSUMIO 1MG/ML INJ,SOLN,30ML | 30ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Follicular | GenentechUSA,Inc. |
| USA | (L01FX26) mirvetuximab soravtansine | ELAHERE 100MG INJ | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms | ImmunoGen,Inc. |
| USA | (L01FX28) glofitamab | COLUMVI 1MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | GenentechUSA,Inc. |
| USA | (L01FX28) glofitamab | COLUMVI 1MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | GenentechUSA,Inc. |
| USA | (L01FX28) glofitamab | COLUMVI 1MG/ML INJ,SOLN | 2.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | GenentechUSA,Inc. |
| USA | (L01FX28) glofitamab | COLUMVI 1MG/ML INJ,SOLN | 2.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | GenentechUSA,Inc. |
| USA | (L01FX29) talquetamab | TALVEY 2MG/ML INJ,SOLN | 1.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FX29) talquetamab | TALVEY 2MG/ML INJ,SOLN | 1.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FX29) talquetamab | TALVEY 40MG/ML INJ,SOLN | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FX29) talquetamab | TALVEY 40MG/ML INJ,SOLN | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FX32) elranatamab | ELREXFIO 44MG/1.1ML INJ,SOLN | 1.1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Pfizer,Inc. |
| USA | (L01FX32) elranatamab | ELREXFIO 44MG/1.1ML INJ,SOLN | 1.1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Pfizer,Inc. |
| USA | (L01FX32) elranatamab | ELREXFIO 76MG/1.9ML INJ,SOLN | 1.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Pfizer,Inc. |
| USA | (L01FX32) elranatamab | ELREXFIO 76MG/1.9ML INJ,SOLN | 1.9ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Pfizer,Inc. |
| USA | (L01FY01) pertuzumab and trastuzumab | PHESGO | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | GenentechUSA,Inc. |
| USA | (L01FY01) pertuzumab and trastuzumab | PHESGO | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | GenentechUSA,Inc. |
| USA | (L01FY01) pertuzumab and trastuzumab | PHESGO | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | GenentechUSA,Inc. |
Pages
